We confirm the major role of activation of the PI3K/Akt/mTOR pathway in ASCC carcinogenesis (45% of tumors samples) as previously described,32, 33 and in particular in recurrences, in which activation of this pathway was present in 66% of tumor samples. The gene discussed is MTOR; the disease is neoplasm.